KIT and digestive system neoplasm: Although previous studies have shown a correlation between clinical efficacy outcomes and c-Kit levels in patients with gastrointestinal tumors [44], this conclusion should be interpreted with caution because of the relatively small sample size in the present study and the complexity of tumor-microenvironment interactions.